Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer

Clinical trial NCT05524584 · RECRUITING

Trial details

NCT number: NCT05524584
Sponsor: University of California, Irvine
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Metastatic Breast Cancer Hormone Receptor-positive Breast Cancer HER2-negative Breast Cancer

Start date: 2022-08-31
Primary completion: 2028-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.